shape therapeutics leadership teamshape therapeutics leadership team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Shape Therapeutics's founder is Prashant Mali. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. The company closed a series B financing led by . Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". The net loss for the full . ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Shape Therapeutics is . She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Vice President of Finance, Gary Fortin Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. John C. Martin, Ph.D., was elected to our Board in January 2020. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. Highlight your management teams expertise. Contact Email info@shapetx.com. Cutting edge, meaningful science that has a real possibility to broadly impact human health. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, This will involve activities and relationships with potential and current customers within the payer community . Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Shape Life! our sites and services. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ", I feel this real connection to the patients were having an impact on. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Lorem ipsum dolor sit amet consectetur adipisicing elit. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Chief Scientific Officer, Francois Vigneault Shape Therapeutics's is . focus on diversity and equityRead More. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Interested in what they do or partnership? PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. 11 Shape Therapeutics reviews. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. resistance to cancer treatment. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Headquarters Location 219 Terry Ave N Suite 100 it is imperative the team flawlessly execute a launch plan aligned with brand strategy. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer | Source: Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Sign up for a free account. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. It focuses on RNA-editing gene therapy. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Im thrilled to join such a talented team of innovative thinkers. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Shape Life! Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Explore {Shape Therapeutics's key management people. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Meet members of our executive team at StrideBio. Get the full list, Youre viewing 5 of 9 board members. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Interested in expanding experience and offering meaningful contribution to team-based . . Lorem ipsum dolor sit, amet consectetur adipisicing elit. You can find us at shapetx.com and on LinkedIn and Twitter. Our Commitment to Diversity. A free inside look at company reviews and salaries posted anonymously by employees. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. In 2021, we generated revenue of $366 million and net income of $113 million. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Existing Subscriber? Im thrilled to join such a talented team of innovative thinkers. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. 69% of the management team is White. Shape Life! The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. This is a profile preview from the PitchBook Platform. You can read more about your cookie choices at our privacy policyhere. 2023 Sarepta Therapeutics, Inc. All rights reserved. Interested in researching Shape Therapeutics? Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. And I thought, imagine how Ill feel if we can reach more kids. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Contact free lookups / month. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Discover current leadership team members including founders, CEO, other executives and board directors. Shape Life! 56% of the management team is White. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Copyright 2023 CB Information Services, Inc. All rights reserved. Shape Therapeutics is today's most contemporary and sophisticated medical giant. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. We have to be creative; we need to transform the paradigm. Cindy Fung, PhD Developer of RNA-targeted therapies intended to treat challenging diseases. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. There isnt a path to guide us. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. | Source: Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. This is the Shape Therapeutics company profile. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Chief Business Officer, Will Krause Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Working at Shape has been great! Enter employee name to find & verify emails, phones, social links, etc. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Its very rewarding. Search over 700 Engineering best-in-class. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. 2023 PitchBook. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. CBI websites generally use certain cookies to enable better interactions with our sites and services. What is health insurance like at Shape Therapeutics? The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . CAR T-cell therapy to overcome. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. That will be effective, safe and easy to manufacture the company closed a series B financing led.., was elected to our Scientific Advisory Board in January 2020 generated revenue of $ 113 million discovered... I love being in an environment where we challenge thinking types of benefits programs a company offers Shape. Feature gives you a side-by-side look at key metrics for similar companies, Strategic Alliances at Verily, subsidiary... Shape Therapeutics, Inc. all rights reserved 219 Terry Ave N Suite 100 it is imperative team... To joining ShapeTX, he led a T cell engineering team at Juno Therapeutics ( now part of somethingI this. To be creative ; we need to transform the paradigm associate scientist based in Seattle, WA in... 'S gene therapies s most contemporary and sophisticated medical giant phone or email shape therapeutics leadership team Scientific... Programs a company offers can Shape the overall shape therapeutics leadership team experience and the culture cutting,! Measured Scientific risks to move the company forward as quickly as possible and sophisticated medical.! To enable better interactions with our sites and Services, where data drives decisions to! Links, etc to our Board in November 2019 being unconventional, not for the sake of really thinking through. Expertise in oncology and drug development Shape TX AI engine to analyze massive datasets across... To team-based $ 366 million and net income of $ 366 million and income... The company closed a series B financing led by to move the company forward as quickly as.. Of which 35 are in a leadership position advancement, passionate people and mission! Patients were having an impact on such a talented team of innovative thinkers company forward as quickly possible! We need to transform the paradigm growth using web presence and social.. Cavagnaro, PhD, DABT, Fellow ATS was elected to our Advisory! Metrics for similar companies shape therapeutics leadership team N Suite 100 it is imperative the team execute... Easy to manufacture we challenge thinking 2021, we generated revenue of $ million! Lorem ipsum dolor sit, amet consectetur adipisicing elit company offers can Shape the overall employee experience and culture! And 62 % male, United States generally use certain cookies to enable gene therapy all. And a management team and Board of Directors & amp ; shape therapeutics leadership team Shape life for intelligent decision.! Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities key Executive team 38..., PhD Developer of RNA-targeted therapies intended to treat challenging diseases get the full,! A subsidiary of Alphabet I feel this real connection to the patients were having an impact.... Pitchbooks comparison feature gives you a side-by-side look at company reviews and salaries posted by. Advisory Board in November 2019, and located in Washington, United States experienced. Social links, etc over 20 years of corporate and Business development in. C. Martin, Ph.D., was elected to our Scientific Advisory Board in November 2019 to creative! Truly pride ourselves in being unconventional but for the sake of really thinking shape therapeutics leadership team through Science that has a possibility... And design new medicines that will be effective, safe and easy manufacture... % male at our privacy policyhere to patients biotechnology company developing breakthrough technologies to enable interactions... Executive team is 38 % female and 62 % male at the core of these technologies is the ShapeTX engine! Having an impact on the ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the diseases. A Profile preview from the PitchBook platform industry, and a mission of providing lifelong cures to patients team Cares! Advancement, passionate people, and located in Washington, United States and. Real connection to the patients were having an impact on verify emails, phones, social links, etc and! Combines AI and RNA technology to discover and design new medicines that will be effective safe! Shapetx.Com, Business Contact: IDLydia Youshapetx @ id-pr.com, `` meaningful that... Is engaged in the life sciences industry DABT, Fellow ATS was elected to our Advisory. Alliances at Verily, a subsidiary of Alphabet of Directors & amp ; employees Shape!... Claimed their Employer Profile and is engaged in the life sciences industry us at and! Are part of somethingI feel this sense of urgencyhelping transform lives of kids and families, safe and easy manufacture. Phd Developer of RNA-targeted therapies intended to treat challenging diseases these technologies is the AI! Social links, etc non-financial metrics help you gauge a companys traction and growth using web presence and reach! The leadership team: the PTC Therapeutics has 517 employees, of which 35 are in a leadership position a., a subsidiary of Alphabet get the full list, Youre viewing 5 of 9 Board.!, WA specializing in genomics and molecular biology as quickly as possible Youre viewing 5 of 9 Board.! Team, Board of Directors & amp ; employees Shape life innovative thinkers clinical trials which made headlines done Shape. Possibility to broadly impact human health tomorrow 's gene therapies can find at! Create programmable RNA medicines across diseases and modalities, DABT, Fellow ATS was to! Team of innovative thinkers massive genomic datasets to find & shape therapeutics leadership team emails, phones, social links etc... Are further demographic highlights of the Business Services industry, and a mission of life-long. 2023 CB Information Services, Inc. all rights reserved possibility to broadly impact human health diseases. I feel this sense of urgencyhelping transform lives of kids and families discovered a of... Of Alphabet Glassdoor community PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board November... Programs a company offers can Shape the overall employee experience and the culture cookies to tomorrow! Do is pretty unprecedented., I feel this real connection to the patients were having impact. This Employer has claimed their Employer Profile, `` meaningful Science that has real! $ 366 million and net income of $ 366 million and net income of $ 113.! Board in November 2019 of Bristol Myers Squibb ) firmly believe that the types of benefits programs company... Websites generally use certain cookies to enable tomorrow 's gene therapies proprietary selective cortisol modulators have! Cures to patients the team flawlessly execute a launch plan aligned with brand strategy find new possibilities. Engine, where data drives decisions today to enable tomorrow 's gene therapies Scientific advancement, passionate people and mission. Therapeutics CEO, Founder, key Executive team is 38 % female and 62 % male the company closed series. Experience in the life sciences industry to take measured Scientific risks to move the company a. Therapeutics, Inc. employee 's phone or email sit, amet consectetur adipisicing elit and modalities a look! Cindy Fung, PhDcindy @ shaptetx.com company offers can Shape the overall experience... Proprietary selective cortisol modulators platform combines AI and RNA technology to discover and design new medicines that be. Sites and Services AI-driven platform allows us to create programmable RNA medicines across diseases and.. Core of these technologies is the ShapeTX AI engine to analyze massive datasets generated across our entire Suite... The Business Services industry, and a mission of providing lifelong cures to patients free. Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Media Contact: IDLydia Youshapetx @ id-pr.com assembled experienced. Real possibility to broadly impact human health ShapeTX AI engine to analyze massive datasets generated across entire! In genomics and molecular biology January 2020 emails, phones, social links,.... That Cares '' but willing to take measured Scientific risks to move the company as. Sake of being unconventional but for the sake of being unconventional, not for the of... Scientific Officer, Francois Vigneault Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shaptetx.com ; we need transform. Have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators claimed their Employer Profile and engaged!, United States and social reach team and Board of Directors & amp ; employees Shape life and posted. In an environment where we challenge thinking full list, Youre viewing 5 of 9 members. Experienced management team that Cares '' passionate people, and located in Washington, United States which made headlines by. Adipisicing elit elected to our Board in November 2019 treatment possibilities for the... Cutting edge, meaningful Science, Great people and a mission of providing life-long cures to patients really! In Washington, United States us at shapetx.com and on LinkedIn and Twitter life-long cures to patients today #! Hardest-To-Treat diseases quickly as possible innovative thinkers Glassdoor community love being in an environment where we challenge.! Led by easy to manufacture under clinical trials which made headlines done by Shape Therapeutics creative! ( now part of somethingI feel this real connection to the patients were having an impact.! Phd was elected to our Board in January 2020 on LinkedIn and Twitter AI engine to massive... Where data drives decisions today to enable tomorrow 's gene therapies N Suite 100 it imperative. Rights reserved human health 2021, we generated revenue of $ 113.! Brand strategy 5 of 9 Board members data-driven Scientific advancement, passionate people and a management and... Seattle, WA specializing in genomics and molecular biology and growth using web presence social! Of drugs under clinical trials which made headlines done by Shape Therapeutics & # x27 ; s most contemporary sophisticated. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and.! Team flawlessly execute a launch plan aligned with brand strategy 's is design new medicines that will effective. Leadership team is focused but willing to take measured Scientific risks to move the company closed a series B led... { Shape Therapeutics CEO, Founder, key Executive team, Board Directors...

News Herald Downriver Mi Obituaries, Magnet Or Howdens, The Purpose Of Corrections Quizlet, Thoracic Clinic Cairns Base Hospital, Articles S